Optimising the radiotherapy planning and treatment for anal cancer
- Conditions
- Anal CancerCancer - Bowel - Anal
- Registration Number
- ACTRN12620000066987
- Lead Sponsor
- Austin Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 11
Inclusion Criteria
•Histologically confirmed SCC Anal Canal confined to the pelvis
•ECOG Performance Status 0-2
•Age > 18 yrs;
•competent to give written informed consent
•Contraindication to MRI such as
•pacemaker
•cochlear implants
•some cardiac stents
•claustrophobia
•Allergy to Gadolinium (DCE scan)
•Contraindication to PET such as
•Poor renal function
•Gross metastatic disease
•Other illness that would impair ability to remain still/stable during treatment
•Healing/bleeding disorder
•Pregnancy
•Previous radiotherapy
•Unable to attend for the full course of treatment or trial related visits.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method